Dalbavancin Use in Persons Who Use Drugs May Increase Adherence Without Increasing Cost
{{output}}
Background: Dalbavancin (DAL) may obviate concerns regarding misuse of IV access in persons who use drugs (PWUD) completing treatment for infections in an outpatient setting. However, hesitancy to adopt its use exists due to the cost-prohibitive nature of DAL ... ...
